In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

David Ridley

Senior Editor

Coventry, UK
David's coverage specializes in OTC medicines, dietary supplements and self-care medical devices. David is interested in regulatory gray areas such as the borderlines between medicines, supplements and medical devices, as well as botanical ingredients. David also regularly speaks to industry leaders and experts about the latest trends to deliver crucial market intelligence to HBW Insight readers, and co-hosts the Over the Counter podcast. In his spare time, David spends time in his allotment garden, reading/watching science fiction and worrying about climate change.

Latest From David Ridley

Over The Counter 20 Feb 2024: AESGP’s 60th Birthday Celebrations In 2024 Including Annual Meeting, With Jurate Švarcaite

The Association of the European Self-Care Industry celebrates its 60th birthday this year. In this episode, we catch up with AESGP director general, Jurate Švarcaite, to find out how the association will mark the occasion, including at this year’s Annual Meeting in Brussels in June. AESGP Annual Meetings are an excellent way to find out what the key issues and trends are impacting the European consumer health industry, and this one will be no different. We talk through some of the key themes of this year’s conference. Sustainability continues to be a mega-trend, closely followed by digitalization and artificial intelligence. With its wide-ranging footprint across OTC medicines, food supplements and self-care medical devices sectors, the consumer health industry is facing an avalanche of regulations, and the AESGP continues to be an effective advocate for its stakeholders, alongside adjacent industry partners. 

Germany Health

Infographic: EU Sustainability Legislation All In One Place

The EU Green Deal brings with it numerous directives, strategies and frameworks which consumer health companies operating in the region must work out how to navigate. To assist companies facing this regulatory storm, HBW Insight has produced an infographic which brings together in one place the main EU legislation supporting the Green Deal.

Europe Health

Half Of European Consumers Seek Pharmacist's Over GP's Advice For Self-Care – Kenvue Survey

Almost half of European respondents to a Kenvue-commissioned survey said they had chosen to visit a pharmacist rather than a doctor for advice about minor ailments in the last year, even though a consultation was necessary from their point of view.

Europe Health

German OTC Launches And Revitalizations From P&G, Stada, Théa and TheOTCLab

Botanical extracts power new products from P&G Health and Théa Pharmaceuticals in the areas of pain and eye-care respectively, while TheOTCLab and Stada relaunch much-loved foot care and cold brands in this German OTC marketing update. 

Germany Health

EU Medicines And Cosmetics Industries Set To Pay At Least 80% Of Wastewater Treatment Costs

The EU's revised Urban Wastewater Treatment Directive is one step closer to implementation thanks to provisional agreement between the European Parliament and Council. In line with the “polluter pays” principle, producers of pharmaceuticals and cosmetics should contribute at least 80% towards the costs of removing micropollutants from wastewater through quaternary treatment, the legislative bodies agree. 

Europe Health

UK Doctors Call For Mass Market Access To Emergency Contraceptive Pill

UK doctors are calling for the reclassification of oral emergency hormonal contraceptives (EHCs) from pharmacy (P) medicine status to general sales list (GSL) status in the country. Manufacturer Maxwellia, which markets levonorgestrel-based emergency contraception, LoviOne, says it "has what it takes to get this over the line" with the UK Medicines and Healthcare products Regulatory Agency. 

United Kingdom Health
See All
UsernamePublicRestriction

Register